✦ LIBER ✦

Treatment-Related Mortality in Patients with AL Amyloidosis Undergoing High-Dose Melphalan and Stem Cell Transplantation: Trend Over The Past 14 Years at a Single Institution

✍ Scribed by V. Sanchorawala; M. Skinner; K.T. Finn; K. Quillen; D.C. Seldin

Book ID: 116280558
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 65 KB
Volume: 15
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2008.12.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose melphalan and stem cell transp

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center

✍ Tsai, S. B.; Seldin, D. C.; Quillen, K.; Berk, J. L.; Ruberg, F. L.; Meier-Ewert 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 161 KB

High-dose idarubicin, cyclophosphamide a

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Long-term, apheresis/hemodialysis cathet

Long-term, apheresis/hemodialysis catheters decrease the incidence of catheter-related blood stream infections (CR-BSI) and venous thrombosis (VT) in patients with al amyloidosis (ALA) undergoing high-dose melphalan and autologous stem cell transplant (AuSCT)

✍ K. Finn; V. Sanchorawala; D. Seldin; R. Kunz; K. Quillen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 72 KB